CNX Coal Resources LP (NYSE:CNXC) has been given a $18.00 target price by equities research analysts at Jefferies Group in a note issued to investors on Wednesday. The firm presently has a a “hold” rating on the stock. Jefferies Group’s price target suggests a potential upside of 4.59% from the stock’s previous close.
A number of other brokerages have also weighed in on CNXC. Zacks Investment Research raised CNX Coal Resources from a “hold” rating to a “buy” rating and set a $17.00 target price for the company in a research report on Thursday, September 22nd. Stifel Nicolaus boosted their target price on CNX Coal Resources from $15.00 to $17.00 and gave the stock a “buy” rating in a research report on Thursday, July 28th. Finally, Citigroup Inc. began coverage on CNX Coal Resources in a research report on Thursday, July 28th. They issued a “neutral” rating and a $14.00 target price for the company. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. CNX Coal Resources currently has an average rating of “Hold” and a consensus target price of $15.00.
CNX Coal Resources (NYSE:CNXC) opened at 17.21 on Wednesday. The stock has a 50 day moving average of $14.28 and a 200-day moving average of $10.55. CNX Coal Resources has a 52-week low of $5.98 and a 52-week high of $19.23. The company has a market capitalization of $399.65 million, a price-to-earnings ratio of 717.08 and a beta of 2.05.
CNX Coal Resources (NYSE:CNXC) last announced its quarterly earnings results on Friday, July 29th. The company reported $0.11 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.13 by $0.02. CNX Coal Resources had a return on equity of 16.14% and a net margin of 12.85%. On average, equities research analysts anticipate that CNX Coal Resources will post $0.84 earnings per share for the current fiscal year.
Several large investors have recently added to or reduced their stakes in CNXC. Howard Hughes Medical Institute raised its stake in CNX Coal Resources by 20.4% in the first quarter. Howard Hughes Medical Institute now owns 37,552 shares of the company’s stock valued at $270,000 after buying an additional 6,353 shares during the last quarter. A.R.T. Advisors LLC acquired a new stake in CNX Coal Resources during the second quarter valued at approximately $150,000. Renaissance Technologies LLC acquired a new stake in CNX Coal Resources during the first quarter valued at approximately $698,000. Finally, Mountain Lake Investment Management LLC raised its stake in CNX Coal Resources by 31.8% in the first quarter. Mountain Lake Investment Management LLC now owns 425,000 shares of the company’s stock valued at $3,052,000 after buying an additional 102,500 shares during the last quarter. 59.04% of the stock is owned by hedge funds and other institutional investors.
CNX Coal Resources Company Profile
CNX Coal Resources LP is a producer of thermal coal in the Northern Appalachian Basin and the eastern United States. The Company is engaged in the management and development of the thermal coal operations of CONSOL Energy Inc (CONSOL Energy) in Pennsylvania. The Company’s assets include interests in CONSOL Energy’s Pennsylvania mining complex, which consists of approximately three underground mines and related infrastructure that produce bituminous thermal coal that is sold primarily to electric utilities in the eastern United States.
Receive News & Ratings for CNX Coal Resources LP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CNX Coal Resources LP and related companies with MarketBeat.com's FREE daily email newsletter.